Saturday, 21 May, 2022
TopicSputnik

Topic: Sputnik

Sputnik V found to be less effective against Beta variant in lab tests, study says

Blood samples from recipients of both doses of Sputnik showed that the vaccine was 6 times less effective against the Beta variant in laboratory tests.

Mixing vaccines without evidence a ‘dangerous’ trend, WHO’s Soumya Swaminathan says

Swaminathan warned that it will be a chaotic situation in countries if citizens start deciding ‘when and who should be taking a second, third or fourth dose’.

Russian Direct Investment Fund, Panacea Biotec launch production of Sputnik V in India

The first batch produced at Panacea Biotec's facilities in Himachal Pradesh will be shipped to Russia for quality control. Full-scale production is expected to start this summer.

Amid vaccine shortage, Delhi govt writes to Dr Reddy’s Labs for 67 lakh Sputnik doses

Earlier Deputy Chief Minister Manish Sisodia claimed that Covaxin manufacturer Bharat Biotech has refused to provide additional doses to the national capital.

Dr Reddy’s administers first dose of Sputnik V vaccine in India

The imported doses of the Covid vaccine, which received regulatory clearance on 13 May, are presently priced at a maximum retail price of Rs 948, with 5% GST per dose.

Covid vaccine Sputnik V has 91.6% efficacy, Lancet report says. Makers expecting India nod

Kirill Dmitriev, CEO of Russian Direct Investment Fund that makes Sputnik V, also says majority of vaccine doses will be manufactured in India.

Oversupply of Covid shot in Russia but skepticism dogs Sputnik V vaccine drive

Not many are taking the Sputnik V vaccine with the low numbers being blamed on Russians’ distrust of officialdom dating back to the Soviet era and doubts over the vaccine.

Pakistan close to granting approval to Russia’s Sputnik Covid vaccine

Pakistan has already ordered 1.2 million doses of Chinese Sinopharm vaccine, with deliveries to start 31 January. It has also given approval to AstraZeneca shot for private use.

‘No safety concerns’ — Dr Reddy’s seeks DCGI nod to continue Sputnik V phase 3 trials

No safety concerns identified during Sputnik V mid-stage trial, data has been submitted to Drugs Controller General of India for a review, Dr. Reddy’s says in a statement.

Russia’s Sputnik V vaccine has no peer-reviewed data yet. Question is — would you take it

Russia hasn’t released late-stage phase 3 data on its vaccine. That said, what we do know about Sputnik V and its design should give us some degree of confidence.

On Camera

YourTurn

Title scene of Taarak Mehta ka ooltah chashmah.

Dear Taarak Mehta, you were our peak comfort content for 14 years. Now it’s time to retire

Just like the Truman Show, all Taarak Mehta plots somehow feel the same for the past few years. It's fine to accept that ideas can go stale.
File photo of chief economic advisor V. Anantha Nageswaran | Photo: Twitter | @FinMinIndia

Stock market turmoil, crypto craze proof of human ‘fear, greed’ says chief economic advisor

Speaking at India Ideas Conclave, organised by think tank India Foundation in Bengaluru, V. Anantha Nageswaran, also said India was now in position to deliver domestically-driven growth'.

Defence

File photo of a defence personnel armed with a SiG 716 rifle near the Line of Control | Photo: Snehesh Alex Philip | ThePrint

India to ink ‘repeat order’ deal for 73,000 SiG 716 rifles from the US

In February 2019, 72,400 SiG 716 rifles of 7.62 x 51mm calibre were contracted from SIG Sauer Inc, USA, under government's 'Buy (Global) category', through fast track procedure.

Mandir or Masjid? New surveys not needed, just acceptance of truth & move towards reconciliation

That temples were destroyed and mosques built is undisputed history. The past can’t be changed, but we can’t deny the wrongs of the past either before we consider reconciliation.
×